TY  - JOUR
TI  - Experience of ibrutinib in a patient with recurrent mantle cell lymphoma with orbital involvement
AB  - Mantle cell lymphoma is a subtype of B cell non-Hodgkin's lymphoma with different clinical and molecular features. Extranodal involvement is common in MCL. Bone marrow, liver, spleen, waldeyer ring and gastrointestinal involvement are most common. Lymphomatosis polyposis can be seen in some patients. Central nervous system involvement is rare. Here, we aimed to present a blastoid variant MCL patient who developed orbital recurrence after four lines of systemic therapy and responded to ibrutinib (560 mg/day) monotherapy. The mass disappeared completely in the bilateral orbital MRI taken after the 5th month of the ibrutinib treatment.
AU  - ERKURT, MEHMET ALI
AU  - BERBER, Ilhami
AU  - SARICI, AHMET
AU  - Biçim, Soykan
AU  - KUKU, IRFAN
AU  - BAHÇECİOĞLU, ÖMER FARUK
AU  - ER ULUBABA, HİLAL
AU  - Kaya, Emin
DO  - 10.5455/medscience.2021.04.139
PY  - 2021
JO  - Medicine Science
VL  - 10
IS  - 4
SN  - 2147-0634
SP  - 1542
EP  - 1545
DB  - TRDizin
UR  - http://search/yayin/detay/504869
ER  -